Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Enovis Corporation Common Stock (NY: ENOV )

43.89 +0.18 (+0.41%)
Official Closing Price Updated: 7:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 391,660
Open 44.19
Bid (Size) 43.75 (3)
Ask (Size) 49.72 (1)
Prev. Close 43.71
Today's Range 43.64 - 44.23
52wk Range 38.27 - 65.03
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Enovis to Host Fourth Quarter and Full Year 2024 Results Conference Call on February 26th
From Enovis Corporation
Via GlobeNewswire
Enovis™ Announces Leadership Change to International Surgical Business
From Enovis Corporation
Via GlobeNewswire

Performance

YTD
-0.93%
-0.93%
1 Month
-3.47%
-3.47%
3 Month
-3.62%
-3.62%
6 Month
-1.83%
-1.83%
1 Year
-25.97%
-25.97%

More News

Read More
Instacart Grows Stronger: S&P MidCap 400 Inclusion, Ulta Partnership Boosts Stock
Via Benzinga
Topics Stocks
Exposures US Equities
Instacart Stock Jumps. It'll Join The S&P MidCap 400 Index.
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
The Latest Analyst Ratings For Enovis
Via Benzinga
Critical Insights From Enovis Analyst Ratings: What You Need To Know
Via Benzinga
Enovis to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
From Enovis Corporation
Via GlobeNewswire
Enovis to Participate in Upcoming Investor Conferences
From Enovis Corporation
Via GlobeNewswire
Enovis Announces Third Quarter 2024 Results
From Enovis Corporation
Via GlobeNewswire
Enovis to Host Third Quarter 2024 Results Conference Call on November 6th
From Enovis Corporation
Via GlobeNewswire
Orthopedic Implant Player Enovis' M&A Strategy Core To Growth And Competitiveness, Analyst Says
Via Benzinga
Enovis Appoints Tim Czartoski as President, U.S. Surgical and Global Product and Enabling Technologies
From Enovis Corporation
Via GlobeNewswire
Enovis™ Introduces the Next Generation of Foot and Ankle Surgery Offerings at AOFAS Annual Meeting
From Enovis Corporation
Via GlobeNewswire
Enovis Continues to Redefine Revision Knee Surgery with the Addition of EMPOWR™ Cones to EMPOWR Revision Knee™, Creating a Comprehensive Portfolio for Efficient Revision Procedures
From Enovis Corporation
Via GlobeNewswire
Enovis™ Introduces STAR® Ankle, now with e+™ Polyethylene for Unmatched Durability
From Enovis Corporation
Via GlobeNewswire
Enovis to Participate in Upcoming Investor Conferences
From Enovis Corporation
Via GlobeNewswire
ENOV Stock Earnings: Enovis Beats EPS, Misses Revenue for Q2 2024
Via InvestorPlace
Enovis Announces Second Quarter 2024 Results
From Enovis Corporation
Via GlobeNewswire
Enovis Announces Time Change for Second Quarter 2024 Results Conference Call
From Enovis Corporation
Via GlobeNewswire
Enovis to Host Second Quarter 2024 Results Conference Call on August 7th
From Enovis Corporation
Via GlobeNewswire
Enovis™ Releases AltiVate Reverse® Glenoid System, Widening Range of Patients Who May be Treated with AltiVate Reverse®
From Enovis Corporation
Via GlobeNewswire
Top 3 Health Care Stocks That Could Blast Off In June
Via Benzinga
5 Medical Info Systems Stocks To Buy For Stable Returns
Via Talk Markets
Enovis to Participate in Upcoming Investor Conferences
From Enovis Corporation
Via GlobeNewswire
Top 4 Health Care Stocks Which Could Rescue Your Portfolio This Month
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.